Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Motor Activity 2Ovarian Neoplasms 1Neoplasms 1

Interventions

Cyclophosphamide 909Carboplatin 786pembrolizumab 741Paclitaxel 741Cisplatin 708Bevacizumab 705Gemcitabine 619Docetaxel 579Rituximab 548Radiotherapy 541Dexamethasone 511Nivolumab 488Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 358Pemetrexed 335Cytarabine 335Oxaliplatin 333Lenalidomide 328Prednisone 326fludarabine phosphate 316Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 276

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Has results × Fitness Trackers × Clear all
NCT03364673 2023-10-13

Stepping Into Survivorship: Harnessing Behavioral Economics to Improve Quality of Life in Ovarian Cancer

Dana-Farber Cancer Institute

Phase NA Completed
29 enrolled 16 charts
Gynecologic

Motor Activity, Ovarian Neoplasms

NCT01778127 2015-05-21

A Web-Based Physical Activity Intervention in Adolescent Survivors of Childhood Cancer

St. Jude Children's Research Hospital

Phase NA Completed
105 enrolled 33 charts

Motor Activity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡